• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Real-time monitoring of respiratory virus-associated hospitalizations: Trends through December 2024 

Real-time monitoring of respiratory virus-associated hospitalizations: Trends through December 2024 

by Truveta staff | Jan 21, 2025 | Research

Overall, the rate of hospitalizations associated with respiratory viruses increased 3-fold between the end of November and end of December (209.2% increase). Respiratory viruses now are associated with 9.3% of all hospitalizations. Rates of influenza-associated...
Exploring mental health-related emergency department visits

Exploring mental health-related emergency department visits

by Truveta Research | Dec 21, 2024 | Research, Research Insights

In an exclusive analysis for the Wall Street Journal, Truveta Research explored mental health-related emergency department visits. The rate of ED encounters related to mental health conditions peaked in 2021 for all conditions studied, besides schizophrenia, which...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends through November 2024 

Real-time monitoring of respiratory virus-associated hospitalizations: Trends through November 2024 

by Truveta staff | Dec 19, 2024 | Research

Between the last week of October and the last week of November, there was a 58.8% increase in respiratory virus-associated hospitalizations. For infants and children under the age of 5, respiratory viruses are now associated with 7.9% of hospitalizations in this...
Exploring first-time GLP-1 prescriptions and new comorbidity diagnoses

Exploring first-time GLP-1 prescriptions and new comorbidity diagnoses

by Truveta Research | Dec 16, 2024 | Research, Research Insights

In partnership with Reuters, Truveta Research explored the percentage of patients who received a first-time diagnosis of type 2 diabetes, cardiovascular disease, or sleep apnea within 15 days of their first-time GLP-1 prescriptions. Truveta Research found that for...
Adderall shortage: Exploring first-time Adderall prescriptions and fill rates

Adderall shortage: Exploring first-time Adderall prescriptions and fill rates

by Truveta Research | Dec 14, 2024 | Research, Research Insights

First-time amphetamine/dextroamphetamine prescription rates remained stable overall, but increased significantly for people 30-44, 45-64, and 65+ years of age. The percentage of prescriptions filled within 5 days of being written reached their lowest values in March...
Adderall shortage: Exploring first-time ADHD diagnosis rates

Adderall shortage: Exploring first-time ADHD diagnosis rates

by Truveta Research | Dec 11, 2024 | Research, Research Insights

The rate of first-time ADHD diagnoses has increased since 2021. The largest increases in first-time ADHD diagnosis rates were seen in the 30-44-year-old and 45-64-year-old age groups. Age groups under 30 years old did not see increases in first-time ADHD diagnosis...
« Older Entries
Next Entries »

Share this


Recent posts

  • New study finds GLP-1 RA medications may significantly reduce risk of alcohol-related hospitalization
  • Understanding the impact of the COVID-19 pandemic on childhood MMR vaccination patterns
  • Shifting trends in TKA fixation: Real-world evidence on the changing landscape of cemented vs uncemented TKA

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice